Your browser doesn't support javascript.
loading
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO).
Vansteenkiste, J; Barlesi, F; Waller, C F; Bennouna, J; Gridelli, C; Goekkurt, E; Verhoeven, D; Szczesna, A; Feurer, M; Milanowski, J; Germonpre, P; Lena, H; Atanackovic, D; Krzakowski, M; Hicking, C; Straub, J; Picard, M; Schuette, W; O'Byrne, K.
Afiliação
  • Vansteenkiste J; Respiratory Oncology Unit, Department of Respiratory Medicine, University Hospitals KU Leuven, Leuven, Belgium johan.vansteenkiste@uzleuven.be.
  • Barlesi F; Multidisciplinary Oncology and Therapeutic Innovations, Aix Marseille University-Assistance Publique Hôpitaux de Marseille, Marseille, France.
  • Waller CF; Haematology, Oncology and Stem Cell Transplantation, University Hospital of Freiburg, Freiburg, Germany.
  • Bennouna J; Département d'Oncologie Médicale, Centre Rene Gauducheau, Saint-Herblain Cedex, France.
  • Gridelli C; Division of Medical Oncology, Azienda Ospedaliera 'S.G. Moscati', Avellino, Italy.
  • Goekkurt E; Department of Oncology, Hematology, Stem Cell Transplantation and Hemostaseology, University Hospital Aachen, Aachen, Germany.
  • Verhoeven D; Iridium Cancer Network, Medical Oncology, AZ Klina, Antwerp, Belgium.
  • Szczesna A; Mazowieckie Centrum Leczenia Chorób Pluc i Gruzlicy, Otwock, Poland.
  • Feurer M; Lungenpraxis Munich, Munich, Germany.
  • Milanowski J; Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.
  • Germonpre P; Pulmonary Medicine, AZ Maria Middelares, Ghent, Belgium.
  • Lena H; Pneumology, CHU Rennes, Rennes, France.
  • Atanackovic D; Oncology/Hematology/Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Krzakowski M; The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Lung and Thoracic Tumours, Warsaw, Poland.
  • Hicking C; Merck KGaA, Darmstadt.
  • Straub J; Merck KGaA, Darmstadt.
  • Picard M; Merck KGaA, Darmstadt.
  • Schuette W; Krankenhaus Martha-Maria Halle-Dölau, Klinik für Innere Medizin II, Halle, Germany.
  • O'Byrne K; Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.
Ann Oncol ; 26(8): 1734-40, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25939894

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Bélgica